Diabetic Renal-Retinal Syndrome

1. Front Matter

   Pages i-xviii

   PDF

2. Effect of Aminoguanidine on Induced-diabetic Rabbits and Diabetic Patients with ESRD

   • Clinton D. Brown, Zhong Zhao, Loraine Thomas, Eli A. Friedman

   Pages 1-5

3. Impact of Nutrition in Uremic Diabetics

   • Morrell Michael Avram

   Pages 7-21

4. New Insights into the Molecular Mechanisms of Vascular Permeability in Diabetes

   • David A. Antonetti, The Penn State Retina Research Group

   Pages 23-33

5. Apoptosis and Neurodegeneration in Diabetes: Lessons from the Retina

   • Alistair J. Barber, Makoto Nakamura, The Penn State Retina Research Group

   Pages 35-45

6. Diabetic Macular Edema

   • Frederick L. Ferris III

   Pages 47-58

7. Diabetic Vitrectomy Update

   • Steven T. Charles

   Pages 59-65

8. Medical Approaches to Preventing Vision Loss from Diabetic Retinopathy

   • Ronald I. Klein, Barbara E. K. Klein

   Pages 67-74

9. Ocular Findings at Onset of Uremia

   • David H. Berman

   Pages 75-88

10. Proliferative Diabetic Retinopathy: Current Treatment Strategies for Progression

    • Jonathan A. Scheindlin

    Pages 89-104

11. Microalbuminuria in Perspectives

    • Carl Erik Mogensen

    Pages 105-120

12. Which Comes First: Renal Injury or Microalbuminuria?

    • S. Michael Mauer, Maria Luiza Avancini Caramori, Paola Fioretto

    Pages 121-128

13. Prevention, Diagnosis and Management of Heart Disease in Patients with Renal Failure

    • Luther T. Clark, Oluwole Abe

    Pages 129-145

14. Reducing Mortality for Diabetic Patients on Hemodialysis

    • Yalemzedwd Worerdekal

    Pages 147-154

15. Long-Term Perspective on Utility of Peritoneal Dialysis in Diabetes

    • Ploumis Passadakis, Dimitrios Oreopoulos

    Pages 155-172

16. Complications of Post-transplant Diabetes

    • Mariana S. Markell

    Pages 173-181

17. Prevalent US Transplant Center Policies Towards Pancreas Transplantation for Patients with Type 2 Diabetes Mellitus

    • Amy L. Friedman, Eli A. Friedman

    Pages 183-189

18. Pancreas Transplantation: Does it Have a Future?

    • John S. Najarian

    Pages 191-195

19. Novel Applications for Recombinant Human Erythropoietin

    • Anthony Cerami, Michael Brines, Cara Cerami, Pietro Ghezzi, Loretta Itri

    Pages 197-206

20. Lessons Learned Since the Last Renal-Retinal Conference

    • Eli A. Friedman

    Pages 207-242

Fresh insights into the pathogenic mechanisms by which hyperglycemia induces tissue and organ injurt are the basis for rapidly evolving promising therapies in diabetes. Especially promising as targets for intervention are products of oxidative stress, including kinins and growth factors. Improving results of renal replacement regimes now incorporating pancreatic islet transplants are able to delay and prevent end-organ damage in diabetic individuals. The evolving story of the taming of diabetes is of direct concern to nephrologists, endocrinologists, ophthalmologists, primary care physicians and medical students.

• Diabetes
• Diabetes mellitus
• Pancreas
• erythropoietin
• growth factor

• Downstate Medical Center, State University of New York, New York, USA

  Eli A. Friedman

• Colombia University, New York, USA

  Francis A. L’Esperance

Policies and ethics